Effects of cerebrolysin® on in vitro primary microglial and astrocyte rat cell cultures

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 21, Issue 5, 1999, Pages 331-338

  Lombardi, Valter R M ^a   Windisch, M ^b   Garcia M ^a   Cacabelos, R ^a  

^a Centro de Investigacion Biomedica EuroEspes   (Spain)

^b Research Initiative Ebewe   (Austria)

Author keywords

1 ; Alzheimer's disease; BDNF; Cerebrolysin; IL; Microglia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN PEPTIDE; CEREBROLYSIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1BETA; NEUROTROPHIC FACTOR; AMINO ACID; INTERLEUKIN 1; NOOTROPIC AGENT;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL COUNT; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; MICROGLIA; NERVE CELL CULTURE; NONHUMAN; RAT; ANIMAL; CELL CULTURE; CELL SEPARATION; IMMUNOHISTOCHEMISTRY; METABOLISM; SPRAGUE DAWLEY RAT; SWINE;

AMINO ACIDS; ANIMALS; ASTROCYTES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL COUNT; CELL SEPARATION; CELLS, CULTURED; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; MICROGLIA; NOOTROPIC AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SWINE;

EID: 0032588976     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.1999.21.5.541910     Document Type: Article

References (33)

1. Lombardi, V.R.M., Maneiro, E., Cacabelos, R. Apoptosis in neurodegenerative diseases: The neuroimmune network. Neurogerontol Neurogeriatr 1998, 2: 105-24.
2. Maneiro, E., Lombardi, V.R.M., Cacabelos, R. Neuroimmune dysfunction in Alzheimer's disease. Neurogerontol Neurogeriatr 1998, 2: 77-104.
3. Davis, E.S., Foster, T.D., Thomas, W.E. Cellular forms and functions of brain microglia. Brain Res Bull 1994, 34: 73-8.
4. Lawson, L.J., Perry, V.H., Dri, P., Gordon, S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 1990, 39: 151-70.
5. Dickson, D.W., Mattiace, L.A., Kure, K., Hutchins, K., Lyman, W.D., Brosnan, C.F. Biology of disease. Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab Invest 1991, 64: 135-55.
6. McGeer, P.L., Itagaki, S., Boyes, B.E., McGeer, E.G. Reactive microglia are positive for HLA-DR in the substancia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988, 38: 1285-91.
7. Dickson, D.W., Lee, S.S., Mattiace, L.A., Yen, S.C., Brosnan, C. Microglia and cytokines in Neurological disease, with special references to AIDS and Alzheimer's disease. Glia 1993, 7: 75-83.
8. Mackanzie, I.R., Hao, C., Munoz, D.G. Role of microglia in senile plaque formation. Neurobiol Aging 1995, 16: 797-804.
9. Aihara, N., Hall, J.J., Pitts, L.H., Fakude, K., Noble, L.J. Altered immunoexpression of microglia and macrophages after mild head injury. J Neurotrauma 1995, 12: 53-63.
10. Shaw, J.A.G., Perry, V.H., Mellanby, J. MHC class II expression by microglia in tetanus toxin-induced experimental epilepsy in the rat. Neuropathol Appl Neurobiol 1994, 20: 392-8.
11. Streit, W.J. The role of microglia in brain injury. Neurotoxicology 1996, 17: 671-8.
12. Koroleva, V.I., Korolev, O.S., Loseva, E., Bures, J. The effect of MK-801 and of brain-derived polypeptides on the development of ischemic lesion induced by photothrombotic occlusion of the distal middle cerebral artery in rats. Brain Res 1998, 786: 104-14.
13. Koppi, S., Barolin, G.S. Hemodilution therapy with neuron metabolism specific therapy in ischemic stroke: Encouraging results of a comparative study. Wien Med Wochenschr 1996, 146: 41-8.
14. Rüther, E., Ritter, R., Apecechea, M., Freytag, S., Windisch, M. Efficacy of the peptidergic nootropic drug Cerebrolysin® in patients with senile dementia of the Alzheimer type (SDAT). Pharmacopsychiatry 1994, 27: 32-40.
15. Rainer, M., Brunnbauer, M., Dunky, A. et al. Therapeutic results with Cerebrolysin® in the treatment of dementia. Wien Med Wochenschr 1997, 147: 426-31.
16. Maneiro, E., Lombardi, V.R.M., Cacabelos, R. Rat cell cultures: Experimental model to study neurodegenerative disorders and new pharmacological compounds. Methods Find Exp Clin Pharmacol 1996, 18: 615-45.
17. Suo, Z.M., Tan, J., Placzek, A., Crawford, F., Fang, C.H., Mullan, M. Alzheimer's beta amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40. Brain Res 1998, 807: 110-7.
18. Knoblach, S.M., Faden, A.L. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp Neurology 1998, 153: 143-51.
19. Rosenwasser, L.J. Biologic activities of IL-1 and its role in human disease. J All Clin Immunol 1998, 102: 344-50.
20. Willard, L.B., HaussWegrzyniak, B., Wenk, G.L. Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience 1998, 88: 193-200.
21. Cacabelos, R., Barquero, M., García, P., Álvarez, X.A., Varela de Seijas, E. Cerebrospinal fluid interleukin-1β (IL-1β) in Alzheimer's disease and neurological disorders. Methods Find Exp Clin Pharmacol 1991, 13: 455-8.
22. Álvarez, X.A., Franco, A., Fernández-Novoa, L., Cacabelos, R. Blood levels of histamine, IL-1β and TNF-α in patients with mild to moderate Alzheimer's disease. Mol Chem Neuropathol 1996, 29: 237-52.
23. Cacabelos, R., Álvarez, X.A., Fernández-Novoa, L. et al. Brain interleukin-1β in Alzheimer's disease and vascular dementia. Methods Find Exp Clin Pharmacol 1994, 16: 141-51.
24. Lombardi, V.R.M., García, M., Cacabelos, R. Microglial activation induced byfactor(s) contained in sera from Alzheimer-related ApoE genotypes. J Neurosci Res 1998, 54: 539-53.
25. Lee, G.J. The possible contribution of microglia and macrophages to delayed neuronal death after ischemia. J Neurol Sci 1993, 114: 119-22.
26. Meda, L., Cassatella, M.A., Szendrei, G.I. et al. Activation of microglia cells by beta amyloid protein and interferon-gamma. Nature 1995, 374: 647-50.
27. Windisch, M., Gschanes, A., Hutter-Paier, B. Neurotrophic activities and therapeutic experience with a brain derived peptide preparation. J Neural Transm 1998, 53(Suppl.): 289-98.
28. Petite, D., Calvet, M.C. Cryopreserved neuronal cells in long-term cultures of dissociated rat cerebral cortex: Survival and morphometric characteristics as revealed by immunocytochemistry. Brain Res 1995, 669: 263-74.
29. Mizuno, H., Asai, K., Fujita, K. et al. Neurotrophic action of lipocortin 1 derived from astrocytes on cultured rat cortical neurons. Mol Brain Res 1998, 60: 28-39.
30. Yang, L.H., Tanaka, J., Zhang, B., Sakanaka, M., Maeda, N. Astrocytes modulate nitric oxide production by microglial cells through secretion of serine and glycine. Biochem Byophys Res Commun 1998, 251: 277-82.
31. Lessmann, V. Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS. Gen Pharmacol 1998, 31: 667-74.
32. KatohSemba, R., Semba, R., Takeuchi, I.K., Kato, K. Age-related changes in levels of brain-derived neurotrophic factor in selected brain regions of rats, normal mice and senescence-accelerated mice: a comparison to those of nerve growth factor and neurotrophin-3. Neurosci Res 1998, 31: 227-34.
33. Cacabelos, R., Takeda, M., Winblad, B. The glutamatergic system and neurodegeneration in dementia: Preventive strategies in Alzheimer's disease. Int J Geriatr Psychiatry 1999, 14: 3-47.